Risedronate (Na)

Risedronate (Na) is a bisphosphate with similar properties to those of bisphosphonates in general. It inhibits bone resorption and is used in Paget`s diseaseof bone and in the treatment of post-menopausal osteoporosis to redce risk of vertebral or hip fractures.

Brands
ATCONATE ATCONATE REDRONA REDRONA OSTEORISE OSTEORISE ROSTEO FREAL AZEBONE REAPKA REAPKA RISONATE RISONATE VALETTA VALETTA BONE-HF BONE-H OSLO OSLO UNIGLOTANATE RISOFOS
Adult Dose
Dose: 5 mg
Single Dose: 5 (5)
Frequency: 24 hourly
Route: PO
Instructions: For treatment and prevention of Postmenopausal Osteoporosis:
Neonatal
Paedriatic
Characteristics
. It is of Synthetic origin. . The Molecular Weight of Risedronate (Na) is 305.10.
Contraindications
Risedronate (Na)
Effects
The symptomatic adverse reactions produced by Risedronate (Na) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Diarrhea, Constipation, Abdominal pain, Nausea and vomiting.
Indications
'Risedronate (Na) is primarily indicated in conditions like Pagets disease, Paget''s disease of bone, Postmenopausal osteoporosis.'
Interactions
No data regarding the interactions of Risedronate (Na) was found.
Interfrence
Risks
Drug should not be given to Pregnant Mothers, and patients suffering from Kidney dysfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Hypocalcemia should be corrected before beginning therapy. Tablets should be taken on rising for the day, on an empty stomach, atleast 30 minutes before breakfast and other oral drug. To minimize the gastro-intestinal effects of the drug patients should be instructed to swallow tablety with plenty of water in an upright position (standing or sitting). Patient should remain upright after taking the tablet and should not lie down for at least 30 minutes.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.